7.28 USD
↘ 0.13 (1.75%)AT CLOSE (03:59 PM EDT)
Immunic, Inc. Common Stock
IMUXNASDAQ • USD
7.29
↗ 0.01 (0.07%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
7.29
↗ 0.01 (0.07%)
Market: CLOSED
IMUX is currently priced at $7.29. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, IMUX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$7.36
High?$7.51
Low?$7.06
Prev. Close?$7.41
Volume?432.3K
Avg. Volume?438.1K
VWAP?$7.20
Rel. Volume?0.99x
Bid / Ask
Bid?$7.06 × 100
Ask?$7.44 × 7.0K
Spread?$0.38
Midpoint?$7.25
Valuation & Ratios
Market Cap?99.3M
Shares Out?13.6M
Float?10.7M
Float %?78.3%
P/E Ratio?N/A
P/B Ratio?0.78
EPS?-$8.18
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
Address
1200 AVENUE OF THE AMERICAS
NEW YORK, X1 10036
Phone: (332) 255-9818
NEW YORK, X1 10036
Phone: (332) 255-9818
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?56
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.54Distress
Confidence?49%Low
Short InterestHigh
Short % of Float?17.45%High
Short Interest?1.9M
Days to Cover?4.1
Free Float10.7M
Avg Daily Volume454.1K
Settlement Date2026-10-15
Financial Health
Current Ratio?5.05Strong
Quick Ratio?5.05Strong
Cash Ratio?4.96Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.78CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.5CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-87.5%WEAK▾
S&P3
ROA?-70.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-88049000
Enterprise Value?$-55766280
Fundamentals ratios updated end of day